Oxandrolone in the Treatment of HIV-Associated Weight Loss in Men: A Randomized, Double-Blind, Placebo-Controlled Study

@article{Grunfeld2006OxandroloneIT,
  title={Oxandrolone in the Treatment of HIV-Associated Weight Loss in Men: A Randomized, Double-Blind, Placebo-Controlled Study},
  author={Carl Grunfeld and Donald P. Kotler and Adrian S Dobs and Marshall J. Glesby and Shalender Bhasin},
  journal={JAIDS Journal of Acquired Immune Deficiency Syndromes},
  year={2006},
  volume={41},
  pages={304-314}
}
Objective: To evaluate the efficacy and safety of oxandrolone in promoting body weight and body cell mass (BCM) gain in HIV-associated weight loss. Methods: Randomized, double-blind, placebo-controlled trial. Two hundred sixty-two HIV-infected men with documented 10% to 20% weight loss or body mass index ≤20 kg/m2 were randomized to placebo or to 20, 40, or 80 mg of oxandrolone daily. After 12 weeks, subjects were allowed to receive open-label oxandrolone at a dose of 20 mg for another 12 weeks… 
Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
TLDR
Whether coadministration of testosterone with MA could enhance lean body mass (LBM) accrual and evaluate the effects of MA, alone or combined with testosterone, on sexual functioning and the hypothalamic-pituitary-adrenal axis is evaluated.
FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL
TLDR
It is demonstrated that administering oxandrolone for up to 2 years following severe burn injury results in greater improvements in BMC, BMD, and height velocity, as well as a reduced risk for future bone fracture.
Effects of Testosterone Supplementation on Body Composition in HIV Patients: A Meta-analysis of Double-blinded Randomized Controlled Trials
This study was designed to evaluate the effects of testosterone supplementation (TS) on body composition in patients with HIV and the side effects of TS. A comprehensive literature search strategy
Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss.
TLDR
In HIV-infected men with weight loss, a supraphysiological dose of testosterone significantly increased FFM but did not improve self-reported or performance-based measures of physical function and improvements in mood, fatigue, and quality of life measures in the testosterone group, although clinically important, need further confirmation.
The Prevalence of Hypogonadism and the Effectiveness of Androgen Administration on Body Composition in HIV-Infected Men: A Meta-Analysis
TLDR
A systematic review confirms the high prevalence of Te deficiency in HIV-infected men, particularly when fT has been considered, and chronic androgen supplementation improves body composition, affecting the lean mass compartment.
Oxandrolone Use Causes Dyslipidemia in Resistance-Training Practitioners
Background: Several of young people and adults make use of anabolic-androgenic steroid (ASS), during resistance training. The purposes of this study were to compare blood and salivary parameters in
Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspension
TLDR
MA-ES may be a preferred formulation of megestrol acetate when managing cachectic patients whose caloric intake is reduced, and bioavailability and absorption are greater for MA-ES than MAOS in fasting subjects.
Androgen deficiency: effects on body composition
TLDR
A recent randomized, placebo-controlled study of physiologic testosterone replacement therapy in women with profound hypoandrogenemia due to hypopituitarism demonstrated an increase in skeletal muscle mass but no change in body fat.
Oxandrolone in the treatment of burn injuries: A systematic review and meta-analysis.
TLDR
There is evidence to suggest that Oxandrolone is a beneficial adjunct to the acute care of burn patients; shortening hospital stays and improving several growth and wound healing parameters, although monitoring liver enzymes is recommended.
Appraisal of current and experimental approaches to the treatment of cachexia
  • F. Strasser
  • Medicine
    Current opinion in supportive and palliative care
  • 2007
TLDR
A number of promising new agents are in development but are not yet regarded as standard of care for primary cachexia, and this void calls for well-designed, proof-of-concept studies followed by placebo-controlled, randomized trials.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 83 REFERENCES
Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
TLDR
Nandrolone decanoate therapy may prove to be generally safe and beneficial in reversing weight loss and lean tissue loss in women with HIV infection and other chronic catabolic diseases.
Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting
TLDR
Oxymetholone can be considered an effective anabolic steroid in eugonadal male and female patients with AIDS-associated wasting and was associated with less, but still significant liver toxicity.
A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
TLDR
It is concluded that nandrolone is superior to placebo and not significantly different from a Food and Drug Administration-approved regimen of rhGH in improving lean body mass in HIV-infected men with mild to moderate weight loss.
A trial of testosterone therapy for HIV‐associated weight loss
TLDR
This randomized, double-blinded study does not confirm the results of other recent studies which show potential benefits of testosterone and its analogs when used as a treatment for weight loss in HIV-positive patients, but appears to produce an improved overall sense of well-being and possibly some increase in muscle strength.
Growth Hormone Improves Lean Body Mass, Physical Performance, and Quality of Life in Subjects With HIV-Associated Weight Loss or Wasting on Highly Active Antiretroviral Therapy
TLDR
Over the 12-week course of therapy, rhGH, 0.1 mg/kg DD, was superior to placebo in improving physical function, body weight, body composition, and QoL and was inferior to AD dosing in restoring LBM.
Treatment with oxandrolone and the durability of effects in older men.
TLDR
Anabolic improvements were lost 12 wk after discontinuing oxandrolone, whereas improvements in fat mass were largely sustained, and short-term improvements in LBM, muscle area, and strength were induced while reducing whole body and trunk adiposity.
Oxandrolone in AIDS‐wasting myopathy
TLDR
Oxandrolone, at a dose of either 5 mg/ day or 15 mg/day, in contrast to placebo, had a positive impact on the weight and well‐being of HIV‐seropositive patients suffering from wasting and weakness.
Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.
TLDR
Treatment with growth hormone increases body weight, lean body mass, and treadmill work output and appears to be a safe and potentially effective therapy in patients with HIV-associated wasting.
Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss.
TLDR
It is concluded that physiological testosterone replacement was safe and effective in raising testosterone levels into the mid to high normal range, but did not significantly increase FFM, body weight, or muscle performance in HIV-infected women with low testosterone levels and mild weight loss.
Sustained anabolic effects of long-term androgen administration in men with AIDS wasting.
TLDR
Testosterone administration results in sustained increases in LBM during 1 year of therapy in hypogonadal men with AIDS wasting, which is consistent with previous studies that have found lean body mass increases after treatment with testosterone.
...
1
2
3
4
5
...